基於奈米技術的藥物傳輸市場- 按技術（奈米晶體、奈米顆粒、脂質體、膠束）、應用（神經學、腫瘤學、心血管/生理學、抗發炎/免疫學、抗感染）、全球預測，2023 - 2032

2023 年至 2032 年，全球基於奈米技術的藥物傳輸市場規模預計複合年成長率將超過 12.5%。越來越多的研究活動探索基於奈米顆粒的口服藥物遞送系統，以提高藥物溶解度和生物利用度，正在徹底改變水溶性差的藥物的遞送。近年來，人們非常關注有效、安全和商業上可行的藥物傳輸平台的開發。生物技術和奈米醫學領域多功能奈米載體平台的不斷進步也將有助於市場的成長。

整個基於奈米技術的藥物傳輸產業根據技術、應用和區域進行細分。

就技術而言，2023年至2032年奈米晶體領域的市場規模可能會出現可觀的複合年成長率。這種成長可歸因於奈米晶體在提高多種藥物的溶解度和生物利用度方面的潛力不斷增加，特別是水溶性差的化合物。奈米晶體還顯著增加了溶解所需的表面積，以增強藥物溶解度，同時透過最小的聚集和分解提供穩定的藥物製劑。

在應用方面，神經病學領域基於奈米技術的藥物傳輸市場將擴大到2032年。奈米材料和奈米粒子提供的獨特性能有助於藥物跨血腦屏障（BBB）以及特定區域的精確輸送大腦內。最近，奈米顆粒也被設計用於促進神經保護劑和溶栓藥物，以限制中風期間和之後的腦損傷。為此，全球神經系統疾病和病症負擔的增加將促進該細分市場的成長。

從地區來看，預計到2032 年，亞太地區基於奈米技術的藥物輸送產業規模將顯著成長。這是由於投資、政府資助、學術研究以及與中國、日本、韓國和其他國家製藥公司的合作不斷增加。印度。癌症負擔的不斷增加也推動了對奈米技術的需求，將化療藥物直接輸送到腫瘤部位，限制全身副作用並提高治療效果。根據美國國立衛生研究院的數據，預計 2022 年印度癌症病例數將達到 14,61,427 例。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：基於奈米技術的藥物傳輸產業見解

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 慢性病盛行率不斷上升
    • 對個人化藥物的偏好日益增加
    • 奈米材料的不斷進步
  • 產業陷阱與挑戰
    • 嚴格的監理政策
    • 奈米藥物傳輸技術成本高
• 成長潛力分析
  • 依技術
  • 按申請
• COVID-19 影響分析
• 監管環境
• 近期進展及未來展望
• FDA 批准的基於奈米技術的產品和臨床試驗
• 波特的分析
• PESTEL分析

第 4 章：競爭格局，2022 年

• 介紹
• 2022 年公司矩陣分析
• 公司定位矩陣
• 主要市場參與者的競爭分析
• 策略儀表板，2022 年

第 5 章：基於奈米技術的藥物傳輸市場規模和預測：按技術分類

• 按技術分類的主要趨勢
• 奈米晶體
• 奈米粒子
• 脂質體
• 膠束
• 其他技術

第 6 章：基於奈米技術的藥物傳輸市場規模與預測：按應用

• 按應用分類的主要趨勢
• 神經病學
• 腫瘤學
• 心血管/生理學
• 抗發炎/免疫學
• 抗感染
• 其他應用

第 7 章：基於奈米技術的藥物傳輸市場規模與預測：按地區

• 按地區分類的主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 中東和非洲其他地區

第 8 章：公司簡介

• AbbVie Inc.
• BlueWillow Biologics
• Camurus AB
• Celgene, Inc.
• Cristal Therapeutics
• Johnson and Johnson
• Merck and Co., Inc
• Nanobiotix
• NanoCarrier Co. Ltd.
• NanOlogy LLC
• Novartis International AG
• Starpharma Holdings Limited

Global nanotechnology-based drug delivery market size is poised to record over 12.5% CAGR from 2023-2032. The rising number of research activities for exploring nanoparticle-based oral drug delivery systems to offer improved drug solubility and bioavailability is revolutionizing the delivery of poorly water-soluble drugs. In recent years, there has been significant focus on the development of effective, safe, and commercially viable drug delivery platforms. The increasing advances in versatile nanocarrier platforms within the biotechnology and nanomedicine space will also contribute to the market growth.

The overall nanotechnology-based drug delivery industry is segmented based on technology, application, and region.

In terms of technology, the market size from the nanocrystals segment may record appreciable CAGR from 2023-2032. The growth can be attributed to the rising potential of nanocrystals in improving the solubility and bioavailability of wide range of drugs, especially in poorly water-soluble compounds. Nanocrystals also significantly augment the surface area needed for dissolution to render enhanced drug solubility whilst providing stable drug formulations via minimal aggregation and degradation.

With respect to application, the nanotechnology-based drug delivery market from the neurology segment will expand up to 2032. The unique properties offered by nanomaterials and nanoparticles help in the precise delivery of drugs across blood-brain barrier (BBB) as well as specific regions within the brain. Lately, nanoparticles are also engineered to facilitate neuroprotective agents and clot-dissolving drugs to limit brain damage during and after strokes. To that end, the rising burden of neurological disorders and conditions worldwide will add to the segment growth.

Regionally, APAC nanotechnology-based drug delivery industry size is projected to observe notable growth rate through 2032. This is due to the rising investments, government funding, academic research, as well as collaborations with pharmaceutical companies in China, Japan, South Korea, and India. The growing burden of cancer is also driving the need for nanotechnology in delivering chemotherapy drugs directly to tumor sites, limiting systemic side effects and enhancing the treatment outcomes. As per the National Institutes for Health, the estimated number of cancer cases in India reached 14,61,427 in 2022.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global nanotechnology-based drug delivery market 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Technology trends
  • 2.1.4 Application trends

Chapter 3 Nanotechnology-based Drug Delivery Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of chronic conditions
    • 3.2.1.2 Increasing preference for personalized medicines
    • 3.2.1.3 Increasing advancements in nanomaterials
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory policies
    • 3.2.2.2 High cost of nanotechnology drug delivery technique
• 3.3 Growth potential analysis
  • 3.3.1 By technology
  • 3.3.2 By application
• 3.4 COVID- 19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Recent advancement and future prospects
• 3.7 FDA-approved nanotechnology-based products and clinical trials
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Company positioning matrix
• 4.4 Competitive analysis of major market players
• 4.5 Strategy dashboard, 2022

Chapter 5 Nanotechnology-based Drug Delivery Market Size and Forecast, By Technology (USD Million)

• 5.1 Key trends, by technology
• 5.2 Nanocrystals
• 5.3 Nanoparticles
• 5.4 Liposomes
• 5.5 Micelles
• 5.6 Other technologies

Chapter 6 Nanotechnology-based Drug Delivery Market Size and Forecast, By Application (USD Million)

• 6.1 Key trends, by application
• 6.2 Neurology
• 6.3 Oncology
• 6.4 Cardiovascular/Physiology
• 6.5 Anti-inflammatory/Immunology
• 6.6 Anti-infective
• 6.7 Other applications

Chapter 7 Nanotechnology-based Drug Delivery Market Size and Forecast, By Region (USD Million)

• 7.1 Key trends, by region
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East & Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 Rest of Middle East & Africa

Chapter 8 Company Profiles

• 8.1 AbbVie Inc.
• 8.2 BlueWillow Biologics
• 8.3 Camurus AB
• 8.4 Celgene, Inc.
• 8.5 Cristal Therapeutics
• 8.6 Johnson and Johnson
• 8.7 Merck and Co., Inc
• 8.8 Nanobiotix
• 8.9 NanoCarrier Co. Ltd.
• 8.10 NanOlogy LLC
• 8.11 Novartis International AG
• 8.12 Starpharma Holdings Limited

Data Tables

• TABLE 1 Market revenue, by technology (2022)
• TABLE 2 Market share, by application (2022)
• TABLE 3 Market share, by region (2022)
• TABLE 4 Global nanotechnology-based drug delivery market size, by region, 2018-2022 (USD Million)
• TABLE 5 Global nanotechnology-based drug delivery market size, by region, 2023-2032 (USD Million)
• TABLE 6 Global nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 7 Global nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 8 Global nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 9 Global nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 10 Industry impact forces
• TABLE 11 Nanocrystals market size, 2018-2022 (USD Million)
• TABLE 12 Nanocrystals market size, 2023-2032 (USD Million)
• TABLE 13 Nanoparticles market size, 2018-2022 (USD Million)
• TABLE 14 Nanoparticles market size, 2023-2032 (USD Million)
• TABLE 15 Liposomes market size, 2018-2022 (USD Million)
• TABLE 16 Liposomes market size, 2023-2032 (USD Million)
• TABLE 17 Micelles market size, 2018-2022 (USD Million)
• TABLE 18 Micelles market size, 2023-2032 (USD Million)
• TABLE 19 Other technologies market size, 2018-2022 (USD Million)
• TABLE 20 Other technologies market size, 2023-2032 (USD Million)
• TABLE 21 Neurology market size, 2018-2022 (USD Million)
• TABLE 22 Neurology market size, 2023-2032 (USD Million)
• TABLE 23 Oncology market size, 2018-2022 (USD Million)
• TABLE 24 Oncology market size, 2023-2032 (USD Million)
• TABLE 25 Cardiovascular/physiology market size, 2018-2022 (USD Million)
• TABLE 26 Cardiovascular/physiology market size, 2023-2032 (USD Million)
• TABLE 27 Anti-inflammatory/immunology market size, 2018-2022 (USD Million)
• TABLE 28 Anti-inflammatory/immunology market size, 2023-2032 (USD Million)
• TABLE 29 Anti-infective market size, 2018-2022 (USD Million)
• TABLE 30 Anti-infective market size, 2023-2032 (USD Million)
• TABLE 31 Other applications market size, 2018-2022 (USD Million)
• TABLE 32 Other applications market size, 2023-2032 (USD Million)
• TABLE 33 North America nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
• TABLE 34 North America nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
• TABLE 35 North America nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 36 North America nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 37 North America nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 38 North America nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 39 U.S. nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 40 U.S. nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 41 U.S. nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 42 U.S. nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 43 Canada nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 44 Canada nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 45 Canada nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 46 Canada nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 47 Europe nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
• TABLE 48 Europe nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
• TABLE 49 Europe nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 50 Europe nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 51 Europe nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 52 Europe nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 53 Germany nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 54 Germany nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 55 Germany nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 56 Germany nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 57 UK nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 58 UK nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 59 UK nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 60 UK nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 61 France nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 62 France nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 63 France nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 64 France nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 65 Spain nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 66 Spain nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 67 Spain nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 68 Spain nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 69 Italy nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 70 Italy nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 71 Italy nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 72 Italy nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 73 Rest of Europe nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 74 Rest of Europe nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 75 Rest of Europe nanotechnology-based drug delivery market size, application, 2018-2022 (USD Million)
• TABLE 76 Rest of Europe nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 77 Asia Pacific nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
• TABLE 78 Asia Pacific nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
• TABLE 79 Asia Pacific nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 80 Asia Pacific nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 81 Asia Pacific nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 82 Asia Pacific nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 83 Japan nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 84 Japan nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 85 Japan nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 86 Japan nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 87 China nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 88 China nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 89 China nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 90 China nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 91 India nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 92 India nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 93 India nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 94 India nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 95 Australia nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 96 Australia nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 97 Australia nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 98 Australia nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 99 Rest of Asia pacific nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 100 Rest of Asia pacific nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 101 Rest of Asia Pacific nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 102 Rest of Asia Pacific nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 103 Latin America nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
• TABLE 104 Latin America nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
• TABLE 105 Latin America nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 106 Latin America nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 107 Latin America nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 108 Latin America nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 109 Brazil nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 110 Brazil nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 111 Brazil nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 112 Brazil nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 113 Mexico nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 114 Mexico nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 115 Mexico nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 116 Mexico nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 117 Argentina nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 118 Argentina nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 119 Argentina nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 120 Argentina nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 121 Rest of Latin America nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 122 Rest of Latin America nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 123 Rest of Latin America nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 124 Rest of Latin America nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 125 Middle East & Africa nanotechnology-based drug delivery market size, by country, 2018-2022 (USD Million)
• TABLE 126 Middle East & Africa nanotechnology-based drug delivery market size, by country, 2023-2032 (USD Million)
• TABLE 127 Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 128 Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 129 Middle East & Africa nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 130 Middle East & Africa nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 131 South Africa nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 132 South Africa nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 133 South Africa nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 134 South Africa nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 135 Saudi Arabia nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 136 Saudi Arabia nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 137 Saudi Arabia nanotechnology-based drug delivery market size, by application, 2018-2022 (USD Million)
• TABLE 138 Saudi Arabia nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)
• TABLE 139 Rest of Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2018-2022 (USD Million)
• TABLE 140 Rest of Middle East & Africa nanotechnology-based drug delivery market size, by technology, 2023-2032 (USD Million)
• TABLE 141 Rest of Middle East & Africa nanotechnology-based drug delivery market size, application, 2018-2022 (USD Million)
• TABLE 142 Rest of Middle East & Africa nanotechnology-based drug delivery market size, by application, 2023-2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Nanotechnology-based drug delivery industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by technology
• FIG 8 Growth potential analysis, by application
• FIG 9 Porter's analysis
• FIG 10 PESTEL analysis
• FIG 11 Company matrix analysis, 2022
• FIG 12 Competitive analysis of major market players, 2022
• FIG 13 Competitive positioning matrix
• FIG 14 Strategic dashboard, 2022